Skip to content
OpenCapital
Get started

QuidelOrtho Corporation QDEL Derivative instruments and other

Derivative instruments and other at other companies

LBR
LB Pharmaceuticals Inc Common StockLBRX
$200K-74.0%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$1.46M+249%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$1.46M+249%
POS
Post HoldingsPOST
$1.7M+131%
Nabors Industries logo
Nabors IndustriesNBR
-$288K-107%
ALH
Alliance Laundry Holdings Inc.ALH
$4.9M+200%

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$921.94M-51.4%
Enterprise value$3.88B-20.1%
P/S0.4×-0.3×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%—

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept qdel:DerivativeInstrumentsAndOther.

The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's derivative instruments and other.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's derivative instruments and other?
QuidelOrtho Corporation (QDEL) reported derivative instruments and other of $2M in Q1 2026.
How has QuidelOrtho Corporation's derivative instruments and other changed year-over-year?
QuidelOrtho Corporation's derivative instruments and other increased by 180.0% year-over-year, from -$2.5M to $2M.
What is the long-term trend for QuidelOrtho Corporation's derivative instruments and other?
Over 2 years (2023 to 2025), QuidelOrtho Corporation's derivative instruments and other has grown at a -47.6% compound annual growth rate (CAGR), from -$29.1M to -$8M.
What does derivative instruments and other mean?
Includes the net gains or losses arising from financial derivative contracts used to hedge risks such as interest rate or currency fluctuations, alongside other miscellaneous non-operating items. It provides insight into the effectiveness of the company's risk management strategies and non-core financial activities.